CyclinB2 and BIRC5 genes as surrogate biomarkers for neurite outgrowth in SH-SY5Y subclonal cells

Neuropharmacology

Volumn 50, Issue 8, 2006, Pages 1041-1047

  Oe, Tomoya ^a,b   Nagashima, Takeyuki ^a   Muramoto, Masakazu ^a,b   Yamazaki, Takao ^a,b   Morikawa, Noriyuki ^a   Okitsu, Osamu ^a   Nishimura, Shintaro ^a   Aoki, Toshiaki ^a   Katayama, Yoshiki ^b   Kita, Yasuhiro ^c  

^a ASTELLAS PHARMA INC   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c PFIZER INC   (United States)

Author keywords

Biomarker; BIRC5; CyclinB2; mRNA level; Neurite outgrowth; SH SY5Y neuroblastoma

Indexed keywords

BIOLOGICAL MARKER; CYCLIN B2; MESSENGER RNA; NERVE GROWTH FACTOR; RETINOIC ACID; TACROLIMUS;

ARTICLE; BACULOVIRAL IAP REPEAT CONTAINING 5 GENE; CELL CLONE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYCLIN B; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE EXPRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LINEAR MODELS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NERVE GROWTH FACTOR; NEURITES; NEUROBLASTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TACROLIMUS; TRETINOIN;

EID: 33646902178     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.02.004     Document Type: Article

References (29)

1. Blanc-Brude O.P., Yu J., Simosa H., Conte M.S., Sessa W.C., and Altieri D.C. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat. Med. 8 (2002) 987-994
2. Chen J., Chattopadhyay B., Venkatakrishnan G., and Ross A.H. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines. Cell Growth Differ. 1 (1990) 79-85
3. Corcoran J., Shroot B., Pizzey J., and Maden M. The role of retinoic acid receptors in neurite outgrowth from different populations of embryonic mouse dorsal root ganglia. J. Cell Sci. 113 (2000) 2567-2574
4. Dobashi Y., Kudoh T., Matsumine A., Toyoshima K., and Akiyama T. Constitutive overexpression of CDK2 inhibits neuronal differentiation of rat pheochromocytoma PC12 cells. J. Biol. Chem. 270 (1995) 23031-23037
5. Dobashi Y., Kudoh T., Toyoshima K., and Akiyama T. Persistent activation of CDK4 during neuronal differentiation of rat pheochromocytoma PC12 cells. Biochem. Biophys. Res. Commun. 221 (1996) 351-355
6. Dobashi Y., Shoji M., Kitagawa M., Noguchi T., and Kameya T. Simultaneous suppression of cdc2 and cdk2 activities induces neuronal differentiation of PC12 cells. J. Biol. Chem. 275 (2000) 12572-12580
7. Eggert A., Ikegaki N., Liu X., Chou T.T., Lee V.M., Trojanowski J.Q., and Brodeur G.M. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells. Oncogene 19 (2000) 2043-2051
8. Erhardt J.A., and Pittman R.N. Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment. J. Biol. Chem. 273 (1998) 23517-23523
9. Gold B.G., Densmore V., Shou W., Matzuk M.M., and Gordon H.S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289 (1999) 1202-1210
10. Gotz R., Karch C., Digby M.R., Troppmair J., Rapp U.R., and Sendtner M. The neuronal apoptosis inhibitory protein suppresses neuronal differentiation and apoptosis in PC12 cells. Hum. Mol. Genet. 9 (2000) 2479-2489
11. Greene L.A., and Kaplan D.R. Early events in neurotrophin signalling via Trk and p75 receptors. Curr. Opin. Neurobiol. 5 (1995) 579-587
12. Greene L.A., and Shooter E.M. The nerve growth factor: biochemistry, synthesis, and mechanism of action. Annu. Rev. Neurosci. 3 (1980) 353-402
13. Jackman M., Firth M., and Pines J. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J. 14 (1995) 1646-1654
14. Jensen L.M. Phenotypic differentiation of aphidicolin-selected human neuroblastoma cultures after long-term exposure to nerve growth factor. Dev. Biol. 120 (1987) 56-64
15. Kaplan D.R., and Miller F.D. Signal transduction by the neurotrophin receptors. Curr. Opin. Cell Biol. 9 (1997) 213-221
16. Kim C.J., Matsuo T., Lee K.H., and Thiele C.J. Up-regulation of insulin-like growth factor-II expression is a feature of TrkA but not TrkB activation in SH-SY5Y neuroblastoma cells. Am. J. Pathol. 155 (1999) 1661-1670
17. Lavenius E., Gestblom C., Johansson I., Nanberg E., and Pahlman S. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor. Cell Growth Differ. 6 (1995) 727-736
18. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
19. LoPresti P., Poluha W., Poluha D.K., Drinkwater E., and Ross A.H. Neuronal differentiation triggered by blocking cell proliferation. Cell Growth Differ. 3 (1992) 627-635
20. Lyons W.E., George E.B., Dawson T.M., Steiner J.P., and Snyder S.H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3191-3195
21. Minshull J., Blow J.J., and Hunt T. Translation of cyclin mRNA is necessary for extracts of activated xenopus eggs to enter mitosis. Cell 56 (1989) 947-956
22. Nicolini G., Miloso M., Zoia C., Di Silvestro A., Cavaletti G., and Tredici G. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity. Anticancer Res. 18 (1998) 2477-2481
23. Norbury C., and Nurse P. Animal cell cycles and their control. Annu. Rev. Biochem. 61 (1992) 441-470
24. Oe T., Sasayama T., Nagashima T., Muramoto M., Yamazaki T., Morikawa N., Okitsu O., Nishimura S., Aoki T., Katayama Y., and Kita Y. Differences in gene expression profile among SH-SY5Y neuroblastoma subclones with different neurite outgrowth responses to nerve growth factor. J. Neurochem. 94 (2005) 1264-1276
25. Pines J. Cyclins and cyclin-dependent kinases: take your partners. Trends Biochem. Sci. 18 (1993) 195-197
26. Poluha W., Poluha D.K., and Ross A.H. TrkA neurogenic receptor regulates differentiation of neuroblastoma cells. Oncogene 10 (1995) 185-189
27. Price R.D., Yamaji T., and Matsuoka N. FK506 potentiates NGF-induced neurite outgrowth via the Ras/Raf/MAP kinase pathway. Br. J. Pharmacol. 140 (2003) 825-829
28. Thoenen H., and Barde Y.A. Physiology of nerve growth factor. Physiol. Rev. 60 (1980) 1284-1335
29. Yankner B.A., and Shooter E.M. The biology and mechanism of action of nerve growth factor. Annu. Rev. Biochem. 51 (1982) 845-868